MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
about
Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative DiseasesUrinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.Melatonergic drugs in development.Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 - 2014).Role of melatonin in embryo fetal developmentSleep Disorders in Postmenopausal WomenDevelopmental effect of light deprivation on synaptic plasticity of rats' hippocampus: implications for melatonin.New perspectives on the development of antiobesity drugs.Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.Quinone reductase 2 as a promising target of melatonin therapeutic actions.Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus.Update on melatonin receptors: IUPHAR Review 20.Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.Melatonin receptors: molecular pharmacology and signaling in the context of system bias.Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.Sleep, Melatonin, and the Menopausal Transition: What Are the Links?Azaindole synthesis through dual activation catalysis with N-heterocyclic carbenes.Design and validation of the first cell-impermeant melatonin receptor agonist.Docking studies for melatonin receptors.Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.
P2860
Q28069509-453D7719-F9D8-49DC-9378-A36C93CB91C6Q34029266-05DC0D59-C8BF-4E93-97BC-FA0728F792C1Q34118849-880BC707-0755-4FE9-B156-8F9A176C5F4EQ34440574-30E6AF9E-4FC3-41A5-9AF3-0600EFE469CAQ34457651-6593AD83-99EE-42A9-BBB3-703B122A68CAQ35045858-30EFAD8C-DA3E-48D2-B2D8-67522D886D9FQ36208657-CC3E7F6F-8027-4556-9555-7B1C48211BA5Q37306951-C511A44E-2282-4D1B-898D-96B283596E76Q38397340-57A321F5-6CAC-46FA-A8A5-68CC1C360C26Q38467876-75D4B268-6FD1-4316-85E0-45C1E32F7DC8Q38606734-92D6A66E-7C4C-4E23-BDFB-86991ADA7375Q38809126-7321B254-8F18-452E-A429-362CB815E83AQ38868297-C9372174-3174-472E-9B41-DAAE67361087Q39128977-B2A1CA44-188D-47B7-8085-EB6FC6DAFE6FQ39434518-D6F6B3E1-F8B3-4825-81E7-9EF229042B57Q41103172-A7907BD6-EC65-40C3-8206-6E3301E899CCQ41181255-63A2B59B-83B8-4CA2-9876-6EF44420BC71Q41668985-F69F755D-F97B-4250-AD8F-709B9F91E940Q42036367-4D2512AF-5171-4A50-A69F-0C4F60C1B15BQ45302101-A308F4D9-7EDF-4C56-8156-79E01D38A828Q52739208-857FEF0D-ADF5-43EE-80A6-34082EA331ECQ55065118-FF8462B2-20CE-4B88-B358-EBF4B117EF08
P2860
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@ast
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@en
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@nl
type
label
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@ast
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@en
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@nl
prefLabel
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@ast
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@en
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
@nl
P50
P356
P1476
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential
@en
P2093
Erika Cecon
Ralf Jockers
P304
P356
10.1021/JM401343C
P407
P577
2013-11-14T00:00:00Z